COPD vs asthma: Learn the difference
COPD and asthma are lung diseases marked by airway inflammation. Uncover differences and overlaps in COPD and asthma, including causes, symptoms, and treatment.
Learn more
HomeArticles
Latest Articles
Decoding Type 2 Inflammation in COPD: An Expert’s Perspective
Understanding type 2 inflammation is the key to managing symptoms and exacerbations of COPD.
Learn more
GOLD Recommendations for Treatment and Management of COPD
Unveiling the Secrets to Optimal COPD Management: The GOLD Report Unraveled Imagine having a comprehensive guide that empowers you to take control of your COPD journey. The GOLD report, a beacon of knowledge, offers invaluable insights into diagnosing, managing, and treating this debilitating condition. This report leaves no stone unturned from tailored pharmacological therapies to groundbreaking non-pharmacological strategies. Discover how the GOLD ABE assessment tool, incorporating symptom evaluation and exacerbation risk, paves the way for personalized treatment plans. Unlock the power of eosinophil counts, a game-changer in predicting treatment responses, and embark on a transformative path toward better respiratory health.
Learn more
An Overview of the impact of Type 2 Inflammation in COPD: Insights from Dr. Surya Bhatt
Chronic Obstructive Pulmonary Disease (COPD) remains a significant health challenge worldwide, characterized by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar abnormalities. Traditionally, COPD has been associated with neutrophil-driven inflammation, but recent insights suggest a more complex picture, involving Type 2 inflammation in a subset of patients. Dr. Surya Bhatt, a renowned COPD researcher and professor of medicine at the University of Alabama at Birmingham, provides valuable insights into this emerging area of COPD research.
Learn more